2008
DOI: 10.1016/j.jpba.2008.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-β-cyclodextrin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
29
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 29 publications
3
29
0
Order By: Relevance
“…The use of the third component as a strategy for significant reduction in the amount of cyclodextrin in desired formulations is well established, however, a few reports are also available showing the adverse effect of the added polymer on solubility [33]. Therefore, cautious screening of the third component is very important.…”
Section: Screening Of the Third Componentmentioning
confidence: 99%
“…The use of the third component as a strategy for significant reduction in the amount of cyclodextrin in desired formulations is well established, however, a few reports are also available showing the adverse effect of the added polymer on solubility [33]. Therefore, cautious screening of the third component is very important.…”
Section: Screening Of the Third Componentmentioning
confidence: 99%
“…Grillo et al(2008) method was modified and the adjustments provided proper separation of NFOH from NF (main hydrolysis degradation product) and from the nanoparticle excipients. Additionally, the improved response made it possible to assess diluted solutions, since high encapsulation efficiency was expected (low amounts of NFOH in the supernatant).…”
Section: Sample Standard Solution and System Suitability Preparationmentioning
confidence: 99%
“…Both parasites have similar metabolism and they belong to the same family: Trypanosomatidae (order Kinetoplastida) (Teixeira et al, 2012). Despite its effectiveness, the formulators have to overcome its poor aqueous solubility (Grillo et al, 2008) aiming for the development of a new generation of antileismaniasis medicines. In this sense, nano-scale drug delivery systems can enable such medicines.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Controlled release systems have been extensively used in the food and pharmaceutical industries for active substances including nutrients, drugs and aromas (El Bahri & Taverdet, 2007;Grillo et al, 2008;Mello et al, 2008;Moraes et al, 2010), and there has been a recent increase in their application in medicine (Natarajan et al, 2011;Parajo et al, 2010;Vicente et al, 2010).…”
Section: Introductionmentioning
confidence: 99%